OPUNIKA

Our Formulation portfolio focuses on evidence-backed Phytopharmaceuticals for present unmet clinical needs. One of the R&D priority area is annihilation of Vector Borne Diseases for which we have been funded through BIRAC (Govt. of India). The R&D pipeline has a few nano-technology formulations aimed at malaria eradication by 2030. We are also developing a highly potent anti-viral agent with immunomodulatory properties under the brand name Punikavir® which has been found suitable for a therapeutic intervention against enveloped viruses like Influenza-A, HIV, RSV, SARS-CoV-2 and Dengue . The portfolio includes functional nutraceuticals, proven to slow down and possibly retard onset of certain chronic diseases and as a potential healthy ageing supplement.
Opunika® is commercially available in the market under AYUSH licence from Drugs Control Administration, Telangana. Physicians over the last few years of its launch in the eastern zone of India, since 2018 onwards, have been prescribing to cure Falciparum Malaria (Brain Malaria) and Vivax Malaria (recurrent Malaria). Opunika® is licenced for use in Children and Adults alike. Please consult your Physician for advice. Learn More…..

CONSYTEL OIL

Consytel® oil has been commercially launched since inception of the company and one of its best selling product. The raw blend of Consytel oil has been imported from Australia and subsequently finished at our manufacturing facility at Hyderabad to produce the 50 ml Roll on formulation.it is chiefly indicated for osteoarthritis and relief of muscular pain with co-existing diabetes and patients with renal impairment since it is purely a topical application without systemic absorption. Consytel® oil is formulated entirely from botanical ingredients and therefore safe for use in Children, Pregnant ladies and high risk patients as specified before.
Consytel® oil contains extracts of Eucalyptus radiata (cineole as bioactive), Melaleuca alternifolia (terpinene-4-ol as bioactive) alongwith vanilla extracts and olive oil as the base. A proprietary blending process binds the bioactives with olive oil for maximal tissue penetration, resulting in reduction of pain and inflammation significantly. A roll on formulation facilitates easy flow and uniform dispersion.

RBC BOOST

RBC Boost® Gesta is a well-designed haematinic for use in pregnancy. It has been formulated in compliance to the latest ICMR 2020 RDA guidelines for Indian pregnant ladies. It also has Lycopene 10% to take care of pre-eclampsia and employs Vit-D3 to increase RBC count, thereby decreasing anaemia.RBC Boost® Gesta is commercially available under FSSAI licence and is poised to become a widely prescribed haematinic.

About Us

Consytel Life Sciences (P) Ltd is a deep life science startup driven by the aspiration to address unmet therapeutic gaps through cogent multimodal solutions. The company has chosen to pursue three distinct verticals-Formulations, Biopharmaceuticals and Medical devices. We are incubated at Atal Incubation Centre (AIC-CCMB), Hyderabad, which is a deep life science incubator in India. We are striving to enhance wellness and wellbeing – we are changing the way of living.